Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
BF-Metoprolol Tablet 100mg
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
BG-71332
BEONE MEDICINES AUS PTY LTD
Healthy Volunteers
1 trial -
BGB-16673
BEONE MEDICINES AUS PTY LTD
Healthy Volunteers
1 trial -
BGB-45035
BEONE MEDICINES AUS PTY LTD
Healthy Participants
1 trial -
BGB-58067
BEONE MEDICINES AUS PTY LTD
Healthy Volunteers
1 trial -
BI 1015550, NERANDOMILAST
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
BI 695502
Boehringer Ingelheim
Healthy
1 trial -
BIA-28-6156-113
BIAL - Portela & Ca
Healthy volunteers
1 trial -
BICX104 naltrexone implantable pellet
BRIGHT MINDS BIOSCIENCES INC.
Healthy Adult Male and Female Volunteers
1 trial -
BIIB115
Biogen
Healthy Volunteer
1 trial -
BIIB122 (DNL151)
Denali Therapeutics
Healthy Volunteers
1 trial -
BMB-101
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
BP45228
Hoffmann-La Roche
Not applicable, healthy volunteers
1 trial -
BP45325
Hoffmann-La Roche
Healthy males volunteers
1 trial -
BP45801
Hoffmann-La Roche
Healthy volunteers
1 trial -
BP45910
Hoffmann-La Roche
Healthy Overweight or Obese
1 trial -
BUSPAR® 30 mg Tablet
Teva Pharma GmbH
Healthy
2 trials -
Bemnifosbuvir (BEM)
Atea Pharmaceuticals
Healthy Volunteer
1 trial -
Bemnifosbuvir (BEM)
Atea Pharmaceuticals
Healthy Volunteer Study
2 trials -
Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditions
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combination
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Benazepril HCl 40 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Benralizumab
AstraZeneca
Healthy Subjects
1 trial -
Bicalutamide
Teva Pharma GmbH
Healthy
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.